Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Parkville SIC, Australia Clinical Trials

A listing of Parkville SIC, Australia clinical trials actively recruiting patients volunteers.

RESULTS

Found (58077) clinical trials

A research study is evaluating the combination of one investigational medication with two FDA-approved medications for high cholesterol. This research study may be an option if you: Are at least 18 years of age or older Have a history of elevated LDL (“bad” cholesterol) levels Are able to stop use ...

Phase N/A

A phase 3 research study of an oral investigational medication as induction and maintenance therapy for adults ages 18 to 75 with moderate to severe ulcerative colitis. Note, study participants may receive the investigational medication or placebo. For more information, please visit our study website at: www.TrueNorthStudy.com

Phase

This research study is for people with advanced liver cancer who have never received systemic medicine (affecting the entire body) for advanced liver cancer. This is a randomized, open-label Phase 3 study to determine whether treatment with vaccinia virus based immunotherapy (Pexa-Vec) followed by sorafenib can slow the progression of ...

Phase

If you’ve been unable to control your blood pressure, or are interested in an alternative to daily medications, you may be a candidate for the RADIANCE-HTN Clinical Study. The investigational study is evaluating a minimally-invasive, catheter-based procedure (the Paradise® Renal Denervation System) which may lower your blood pressure and reduce ...

Phase N/A

The purpose of the study is to examine the effectiveness and tolerability of a vaccine for C-diff infection in participants age 50 or older. This study is expected to last between 18 and 42 months and will require 5 office visits within the first 7 months. Participation includes 3 injections ...

Phase N/A

Clinical Trials of Texas, Inc. is conducting a research study of an investigational medication for patients with non-alcoholic fatty liver disease accompanied by high cholesterol. Non-alcoholic Fatty Liver disease doesn’t usually have symptoms, but you may be at risk if you are overweight and fatigued. Qualified participants receive study-related medical ...

Phase N/A

The purpose of this study is to determine whether FT218 is safe and effective for the treatment of excessive daytime sleepiness and cataplexy in subjects with narcolepsy.

Phase

All subjects in the study will have had loss of response or intolerance to conventional medication used to treat Crohn’s disease.

Phase N/A